SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-189498
Filing Date
2021-06-14
Accepted
2021-06-14 07:12:59
Documents
3
Period of Report
2021-06-14
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d161615d8k.htm 8-K 20685
2 EX-99.1 d161615dex991.htm EX-99.1 8667
3 GRAPHIC g161615dsp006.jpg GRAPHIC 4145
  Complete submission text file 0001193125-21-189498.txt   36735
Mailing Address 500 ARSENAL STREET SUITE 100 WATERTOWN MA 02472
Business Address 500 ARSENAL STREET SUITE 100 WATERTOWN MA 02472 617-679-1970
Forma Therapeutics Holdings, Inc. (Filer) CIK: 0001538927 (see all company filings)

IRS No.: 371657129 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39333 | Film No.: 211013284
SIC: 2836 Biological Products, (No Diagnostic Substances)